logo dark logoo light logo
  • 主頁
  • AM1480
  • AM1380
  • 華語電視 Sino TV
  • 聯繫我們
  • 抗疫送暖
logo dark logoo light logo
  • 主頁
  • AM1480
  • AM1380
  • 華語電視 Sino TV
  • 聯繫我們
  • 抗疫送暖
mobile logo
  • 主頁
  • AM1480
  • AM1380
  • 華語電視 Sino TV
  • 聯繫我們
  • 抗疫送暖
July 22, 2021
Uncategorized

佛奇稱未被告知放緩檢測疫苗有望年底或明年初問世

國家過敏和傳染病研究院院長佛奇(Anthony Fauci)週二在國會表示,從未被告知要放緩新冠檢測,回應總統特朗普早先在造勢大會說「已告知官員放緩檢測」;對於年底或明年初問世有效疫苗,佛奇表示謹慎樂觀。

眾院能源與商業委員會23日就「特朗普政府應對新冠危機的失察」舉行聽證,佛奇、聯邦疾病防治中心(CDC)主任芮斐德(Robert Redfield)、衛福部助理部長吉羅爾(Brett P. Giroir)、聯邦食品暨藥物管理局(FDA)局長哈恩與會作證。會上談到特朗普上周末在奧克拉荷馬州土耳沙造勢大會上宣稱「已告知官員放緩新冠檢測,因為美國確診數激增」,儘管白宮方面已澄清說這是在開玩笑,但特朗普23日回應記者提問時又說自己不開玩笑。

不過佛奇等四名作證者均表示,從未被告知要放緩新冠檢測;佛奇說,「我很確定我們沒人被告知要放緩檢測,實際上,我們還會做更多檢測。」佛奇說,目前許多州確診數激增令人不安,例如佛州、德州、亞利桑納州,但紐約等州在控制疫情和減少確診方面已取得效果,未來數周對於能否應對德州、佛州等州的確診激增極為關鍵。

他並指出,自己對今年年底或明年年初問世有效疫苗持謹慎樂觀態度,政府正為14個候選疫苗提供資金支持。

分享:

SHARE THIS ARTICLE

by admin
0
0
Previous post 競選活動第二站特朗普今訪問亞利桑那州
Next post 波頓:特朗普無視新冠疫情早期預警跡象

即時新聞

俄克拉荷馬州發生氨氣洩漏事故 數十人送醫

November 13, 2025

紐約市議會通過法案 擴大路邊垃圾箱投放範圍

November 13, 2025

加州50號提案涉種族歧視 司法部提訴訟

November 13, 2025

抗議勞資談判缺乏進展 星巴克65家門市罷工

November 13, 2025

川普簽署撥款法案 結束43天創紀錄政府停擺

November 13, 2025
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

CookieDurationDescription
cookielawinfo-checbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.

Performance

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

Analytics

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

Advertisement

Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.

Others

Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.

SAVE & ACCEPT

Terms and Conditions - Privacy Policy